Loading institutional data...
Loading institutional data...
Held by 228 of 5,944 reporting institutions (92th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 18%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $166M covers all $19M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2024-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~9.9% on $18M of debt.
Cash of $166M fully covers short-term debt of $2M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $4.69 today, the market must believe free cash flow compounds -1.7%/yr for a decade (off $54M normalized FCF).
The market's -1.7% is more conservative than its 9-yr track record.
2-stage DCF · 0.15B shares · net debt -$148M
mean 18.1% · volatility σ 190% · implied rate exceeded in 3/5 yrs
Central path = implied -1.7%/yr growth; shaded band = ±1σ (190%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $73M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $418.6M 100.0% | $348.9M 100.0% | $321.5M 100.0% | $267.8M 100.0% | $242.0M 100.0% | $248.2M 100.0% | $299.3M 100.0% | $359.1M 100.0% | $321.1M 100.0% | $221.7M 100.0% |
| Cost of Revenue | $73.0M 17.4% | $60.1M 17.2% | $54.6M 17.0% | $48.3M 18.0% | $39.6M 16.4% | $39.3M 15.8% | $43.1M 14.4% | $36.4M 10.1% | $35.2M 11.0% | $30.9M 14.0% |
| Cost of Products | — | — | — | — | — | — | — | — | — | $32.4M 14.6% |
| Gross Profit | $345.6M 82.6% | $288.8M 82.8% | $266.8M 83.0% | $219.5M 82.0% | $202.4M 83.6% | $208.9M 84.2% | $256.2M 85.6% | $322.7M 89.9% | $285.9M 89.0% | $190.8M 86.0% |
| Research & Development | $15.1M 3.6% | $12.3M 3.5% | $12.7M 3.9% | $12.7M 4.7% | $9.9M 4.1% | $11.7M 4.7% | $11.1M 3.7% | $15.8M 4.4% | $17.9M 5.6% | $14.3M 6.5% |
| Selling, General & Admin | $266.2M 63.6% | $225.1M 64.5% | $211.1M 65.7% | $208.7M 77.9% | $194.8M 80.5% | $181.0M 72.9% | $198.2M 66.2% | $258.5M 72.0% | $220.1M 68.5% | $173.4M 78.2% |
| Operating Income | $63.9M 15.3% | $58.9M 16.9% | $37.1M 11.5% | -$14.7M -5.5% | -$7.1M -2.9% | -$45.4M -18.3% | -$21.2M -7.1% | -$3.9M -1.1% | $46.2M 14.4% | $884K 0.4% |
| Interest Expense | $1.8M 0.4% | $3.9M 1.1% | $6.6M 2.0% | $5.0M 1.9% | — | — | — | — | — | $339K 0.2% |
| Interest & Investment Income | $4.7M 1.1% | $2.9M 0.8% | $118K 0.0% | $32K 0.0% | — | — | — | — | — | — |
| Other Income (Expense), net | -$558K -0.1% | -$565K -0.2% | -$26K -0.0% | -$4K -0.0% | -$23K -0.0% | -$3K -0.0% | $283K 0.1% | $0 0.0% | $0 0.0% | -$339K -0.2% |
| Pretax Income | $66.3M 15.8% | $57.3M 16.4% | $30.6M 9.5% | -$19.7M -7.4% | -$12.1M -5.0% | -$61.5M -24.8% | -$25.6M -8.5% | -$3.4M -0.9% | $45.1M 14.0% | $545K 0.2% |
| Income Tax Expense | $17.7M 4.2% | $15.3M 4.4% | -$36.8M -11.4% | $206K 0.1% | $247K 0.1% | -$12.3M -4.9% | -$5K -0.0% | $26.6M 7.4% | -$19.6M -6.1% | $155K 0.1% |
| Net Income | $48.6M 11.6% | $42.4M 12.2% | $58.2M 18.1% | -$30.2M -11.3% | -$10.3M -4.2% | -$49.3M -19.9% | -$25.6M -8.5% | -$30.0M -8.3% | $64.7M 20.2% | $390K 0.2% |
| Per Share | ||||||||||
| EPS (Basic) | $0.33 | $0.29 | $0.40 | $-0.33 | $-0.15 | $-0.77 | $-0.24 | $-0.28 | $0.61 | $0.00 |
| EPS (Diluted) | $0.32 | $0.28 | $0.37 | $-0.33 | $-0.15 | $-0.77 | $-0.24 | $-0.28 | $0.56 | $0.00 |
| Weighted Avg Shares (Basic) | 147.8M | 147.0M | 116.5M | 112.9M | 110.4M | 108.3M | 106.9M | 105.6M | 106.1M | 105.9M |
| Weighted Avg Shares (Diluted) | 149.7M | 149.0M | 146.0M | 112.9M | 110.4M | 108.3M | 106.9M | 105.6M | 116.1M | 112.6M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| MDXG | $695M | 14.7× | 6.9× | 1.7× | 20.0% | 82.6% | 11.6% | 18.9% | 17.7% | 0.2× | 228 |
Peers = companies sharing MDXG's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 14-yr range · 4th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 10.1 | 14.4 | 15.8 | 16.4 | 18.0 | 17.0 | 17.2 | 17.4 |
| Gross Profit | 89.9 | 85.6 | 84.2 | 83.6 | 82.0 | 83.0 | 82.8 | 82.6 |
| R&D | 4.4 | 3.7 | 4.7 | 4.1 | 4.7 | 3.9 | 3.5 | 3.6 |
| SG&A | 72.0 | 66.2 | 72.9 | 80.5 | 77.9 | 65.7 | 64.5 | 63.6 |
| Operating Income | -1.1 | -7.1 | -18.3 | -2.9 | -5.5 | 11.5 | 16.9 | 15.3 |
| Income Tax | 7.4 | -0.0 | -4.9 | 0.1 | 0.1 | -11.4 | 4.4 | 4.2 |
| Net Income | -8.3 | -8.5 | -19.9 | -4.2 | -11.3 | 18.1 | 12.2 | 11.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MDXG: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.